CAS 1642303-38-5

ITI-214

CAS : 1642303-38-5

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members, exhibits potent PDE1 inhibitory activity.

Formule : C₂₉H₂₉FN₇O₅P

Degré de pureté : 98.21%

Couleur et forme : Solid

Masse moléculaire : 605.56

Ref: TM-T11689

ITI-214

CAS : 1642303-38-5

ITI-214

Degré de pureté : ≥98%

Masse moléculaire : 605.56g/mol

Ref: 54-BUP05064

ITI-214

Produit contrôlé

CAS : 1642303-38-5

ITI-214 is a novel non-steroidal anti-inflammatory drug (NSAID) that has been shown to have potent anti-inflammatory and analgesic effects in animal models. ITI-214 targets phosphodiesterases, which are enzymes that break down the signaling molecule cyclic AMP. This leads to an increase in cyclic AMP levels, which can then activate protein kinase A and inhibit the production of pro-inflammatory cytokines. The safety profile of ITI-214 has been evaluated in clinical studies involving humans with osteoarthritis and rheumatoid arthritis. The drug was well tolerated and did not produce any serious adverse events.
ITI-214 also has other physiological functions, including the enhancement of locomotor activity and blood pressure control.

Formule : C₂₉H₂₉FN₇O₅P

Degré de pureté : Min. 95%

Masse moléculaire : 605.56 g/mol

Ref: 3D-SQC30338